Pharmaceutical innovation knows few boundaries in research today. Scientists are sharing ideas across disciplines, networking with colleagues from diverse fields, and seeking collaborative pathways to develop new pharmaceuticals. The legal landscape for the pharmaceutical industry is also continuously changing. To successfully traverse that landscape requires strong intellectual property and a pathway through the regulatory terrain, challenges faced in the life of every new drug. Companies and universities now often combine efforts, resources, and roles to bring a drug to market. These relation­ships add yet another dimension to the legal landscape for pharmaceuticals. This conference will look across that landscape and give direction for charting a course. Focusing on current issues, industry experts will address what is happening today and look forward to what we can expect in the future.